Paydirt
KC
Insider

Kyle Carver

Chief Financial Officer

Kyle Carver (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Evommune, Inc. (EVMN). The largest single filing was $415K of EVMN (18,175 sh × $22.84, as filed), executed May 28.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$415K
shares × price, as filed
Last traded
May 28
Filed Jun 1

Median ADV $8.9M across their filed names

Open performance→
Volume by month
$415K$208K$0Oct 2024Apr 2025Oct 2025Apr 2026Jun 2026 · sells $415K
Buys $0 Sells $415K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
EVMN Evommune, Inc. EVMN · 0 buys · 1 sell 1 filing
Recent filings
EVMNSALE Evommune, Inc. View filing → $415K
18,175 sh × $22.84
Exec May 28
Filed Jun 1 · 5:30 PM ET